Mylan NV (NASDAQ:MYL)

73.89
Delayed Data
As of May 01
 +1.63 / +2.26%
Today’s Change
44.80
Today|||52-Week Range
76.69
+31.08%
Year-to-Date

Today’s Trading

Previous close72.26
Today’s open72.72
Day’s range-- - --
Volume8,592,734
Average volume (3 months)8,484,053
Market cap$36.2B
Dividend yield--
Data as of 05/01/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+16.15%
Earnings growth (next 5 years)+11.45%
Revenue growth (last year)+12.42%
P/E ratio31.8
Price/Sales2.71
Price/Book8.52

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+3.27+1.93%
VRTXVertex Pharmaceutica...+2.32+1.88%
PRGOPerrigo Company PLC+2.98+1.63%
SHPGShire+0.39+0.16%
Data as of 4:01pm ET, 05/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.71
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers